505 related articles for article (PubMed ID: 33098813)
41. Differences of blood cells, lymphocyte subsets and cytokines in COVID-19 patients with different clinical stages: a network meta-analysis.
Yan W; Chen D; Bigambo FM; Wei H; Wang X; Xia Y
BMC Infect Dis; 2021 Feb; 21(1):156. PubMed ID: 33557779
[TBL] [Abstract][Full Text] [Related]
42. Effect of blood analysis and immune function on the prognosis of patients with COVID-19.
Fu YQ; Sun YL; Lu SW; Yang Y; Wang Y; Xu F
PLoS One; 2020; 15(10):e0240751. PubMed ID: 33125396
[TBL] [Abstract][Full Text] [Related]
43. Laboratory analysis of symptomatic and asymptomatic pregnant patients with SARS-CoV-2 infection.
Fisher SA; Goldstein JA; Mithal LB; Isaia AL; Shanes ED; Otero S; Miller ES
Am J Obstet Gynecol MFM; 2021 Nov; 3(6):100458. PubMed ID: 34403821
[TBL] [Abstract][Full Text] [Related]
44. Severity of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Pregnancy in Ontario: A Matched Cohort Analysis.
Murison KR; Grima AA; Simmons AE; Tuite AR; Fisman DN
Clin Infect Dis; 2023 Feb; 76(3):e200-e206. PubMed ID: 35792660
[TBL] [Abstract][Full Text] [Related]
45. Distinguishable Immunologic Characteristics of COVID-19 Patients with Comorbid Type 2 Diabetes Compared with Nondiabetic Individuals.
Zhao R; Sun Y; Zhang Y; Wang W; Wang S; Wang C; Liu J; Gao L; Hu Z; Fei J; Hou X; Zheng H; Chen L
Mediators Inflamm; 2020; 2020():6914878. PubMed ID: 33061829
[TBL] [Abstract][Full Text] [Related]
46. Clinical course of coronavirus disease-2019 in pregnancy.
Pereira A; Cruz-Melguizo S; Adrien M; Fuentes L; Marin E; Perez-Medina T
Acta Obstet Gynecol Scand; 2020 Jul; 99(7):839-847. PubMed ID: 32441332
[TBL] [Abstract][Full Text] [Related]
47. Sex- and age-specific clinical and immunological features of coronavirus disease 2019.
Jin S; An H; Zhou T; Li T; Xie M; Chen S; Chen C; Ying B; Xu Z; Li X; Li M
PLoS Pathog; 2021 Mar; 17(3):e1009420. PubMed ID: 33770147
[TBL] [Abstract][Full Text] [Related]
48. [Analysis of the clinical characteristics and early warning model construction of severe/critical coronavirus disease 2019 patients].
Xu J; Zhao F; Han M; Ma L; Zhang T
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Apr; 32(4):401-406. PubMed ID: 32527341
[TBL] [Abstract][Full Text] [Related]
49. Fibrinolysis Shutdown Correlation with Thromboembolic Events in Severe COVID-19 Infection.
Wright FL; Vogler TO; Moore EE; Moore HB; Wohlauer MV; Urban S; Nydam TL; Moore PK; McIntyre RC
J Am Coll Surg; 2020 Aug; 231(2):193-203.e1. PubMed ID: 32422349
[TBL] [Abstract][Full Text] [Related]
50. Characteristics of Women of Reproductive Age with Laboratory-Confirmed SARS-CoV-2 Infection by Pregnancy Status - United States, January 22-June 7, 2020.
Ellington S; Strid P; Tong VT; Woodworth K; Galang RR; Zambrano LD; Nahabedian J; Anderson K; Gilboa SM
MMWR Morb Mortal Wkly Rep; 2020 Jun; 69(25):769-775. PubMed ID: 32584795
[TBL] [Abstract][Full Text] [Related]
51. A meta-analysis of SARS-CoV-2 patients identifies the combinatorial significance of D-dimer, C-reactive protein, lymphocyte, and neutrophil values as a predictor of disease severity.
Singh K; Mittal S; Gollapudi S; Butzmann A; Kumar J; Ohgami RS
Int J Lab Hematol; 2021 Apr; 43(2):324-328. PubMed ID: 33010111
[TBL] [Abstract][Full Text] [Related]
52. Neutrophil-to-lymphocyte ratio predicts critical illness patients with 2019 coronavirus disease in the early stage.
Liu J; Liu Y; Xiang P; Pu L; Xiong H; Li C; Zhang M; Tan J; Xu Y; Song R; Song M; Wang L; Zhang W; Han B; Yang L; Wang X; Zhou G; Zhang T; Li B; Wang Y; Chen Z; Wang X
J Transl Med; 2020 May; 18(1):206. PubMed ID: 32434518
[TBL] [Abstract][Full Text] [Related]
53. Case report: Complex evaluation of coagulation, fibrinolysis and inflammatory cytokines in a SARS-CoV-2 infected pregnant woman with fetal loss.
Tóth EL; Orbán-Kálmándi R; Bagoly Z; Lóczi L; Deli T; Török O; Molnár S; Baráth S; Singh P; Hevessy Z; Katona É; Fagyas M; Szabó AÁ; Molnár S; Krasznai ZT
Front Immunol; 2024; 15():1329236. PubMed ID: 38449857
[TBL] [Abstract][Full Text] [Related]
54. Predictive value of the neutrophil to lymphocyte ratio for disease deterioration and serious adverse outcomes in patients with COVID-19: a prospective cohort study.
Zeng ZY; Feng SD; Chen GP; Wu JN
BMC Infect Dis; 2021 Jan; 21(1):80. PubMed ID: 33461497
[TBL] [Abstract][Full Text] [Related]
55. Coagulation assessment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) infected pregnant women and their offspring by using rotational thromboelastometry (ROTEM).
Mitsiakos G; Gialamprinou D; Kontovazainitis CG; Moraitis A; Katsaras G; Pouliakis A; Diamanti E
J Perinat Med; 2024 Mar; 52(3):327-342. PubMed ID: 38353249
[TBL] [Abstract][Full Text] [Related]
56. The clinical implication of dynamic neutrophil to lymphocyte ratio and D-dimer in COVID-19: A retrospective study in Suzhou China.
Fu J; Kong J; Wang W; Wu M; Yao L; Wang Z; Jin J; Wu D; Yu X
Thromb Res; 2020 Aug; 192():3-8. PubMed ID: 32407937
[TBL] [Abstract][Full Text] [Related]
57. COVID-19 and Cancer: Discovery of Difference in Clinical Immune Indexes.
Zeng X; Jiang X; Yang L; Pan Y; Li Y
J Immunol Res; 2021; 2021():8669098. PubMed ID: 34712741
[TBL] [Abstract][Full Text] [Related]
58. Retrospective analysis of laboratory testing in 54 patients with severe- or critical-type 2019 novel coronavirus pneumonia.
Li Y; Hu Y; Yu J; Ma T
Lab Invest; 2020 Jun; 100(6):794-800. PubMed ID: 32341519
[TBL] [Abstract][Full Text] [Related]
59. Prediction of adverse clinical outcomes in patients with coronavirus disease 2019.
Shi S; Liu X; Xiao J; Wang H; Chen L; Li J; Han K
J Clin Lab Anal; 2021 Jan; 35(1):e23598. PubMed ID: 32989838
[TBL] [Abstract][Full Text] [Related]
60. The hemocyte counts as a potential biomarker for predicting disease progression in COVID-19: a retrospective study.
Zheng Y; Zhang Y; Chi H; Chen S; Peng M; Luo L; Chen L; Li J; Shen B; Wang D
Clin Chem Lab Med; 2020 Jun; 58(7):1106-1115. PubMed ID: 32352397
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
